2.87
Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie
Organogenesis (ORGO) VP amends Form 4 for equity grant and tax withholding - Stock Titan
ORGO (Organogenesis) CEO amends Form 4 for stock grant and tax share disposal - Stock Titan
[Form 4/A] Organogenesis Holdings Inc. Amended Insider Trading Activity - Stock Titan
Organogenesis (ORGO) VP updates Form 4 for award vesting and tax shares - Stock Titan
Organogenesis (NASDAQ: ORGO) officer amends Form 4 for award and tax-withheld shares - Stock Titan
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2025 Earnings Call Transcript - Insider Monkey
ORGO PE Ratio & Valuation, Is ORGO Overvalued - Intellectia AI
Wall Street Zen Downgrades Organogenesis (NASDAQ:ORGO) to Hold - MarketBeat
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Unveiling a Potential 116% Upside in Healthcare Innovation - DirectorsTalk Interviews
Organogenesis (ORGO) CAO files Form 3 detailing stock and RSUs - Stock Titan
Organogenesis (NASDAQ:ORGO) Price Target Cut to $8.00 by Analysts at BTIG Research - MarketBeat
Organogenesis Holdings (ORGO) Margin-Driven Profitability Shift Tests Revenue Concern Narratives - Sahm
Organogenesis Q4 Earnings Call Highlights - Yahoo Finance
Organogenesis Holdings Inc (ORGO) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid ... - Investing.com Canada
Organogenesis (ORGO) Q4 2025 Earnings Transcript - AOL.com
ORGO: Record Q4 revenue, but 2026 guidance signals a sharp decline before expected recovery - TradingView
Organogenesis: Q4 Earnings Snapshot - Barchart.com
Earnings call transcript: Organogenesis Q4 2025 beats expectations but faces market challenges - Investing.com UK
Organogenesis Holdings Inc. (ORGO) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
ORGO: Record 2025 results, but 2026 revenue expected to decline due to CMS changes before recovery - TradingView
Wound-care firm Organogenesis hits record sales, warns 2026 drop up to 38% - Stock Titan
Organogenesis Holdings Q4 Earnings Report: What Investors Need to Know - Sahm
A Preview Of Organogenesis Hldgs's Earnings - Benzinga
Published on: 2026-02-25 08:32:12 - baoquankhu1.vn
Organogenesis Holdings Inc expected to post earnings of 21 cents a shareEarnings Preview - TradingView
Organogenesis Names Patrick McGuire Chief Accounting Officer - The Globe and Mail
Organogenesis (Nasdaq: ORGO) appoints Patrick McGuire as CAO - Stock Titan
Organogenesis Holdings Inc. Announces Executive Changes, Effective February 18, 2026 - marketscreener.com
Organogenesis (NASDAQ: ORGO) legal chief granted options, RSUs and settles taxes - Stock Titan
Executive equity awards at Organogenesis (ORGO) include RSUs, options and tax withholding - Stock Titan
Organogenesis Holdings (NASDAQ: ORGO) COO gets new stock and option awards - Stock Titan
Equity grant gives Organogenesis (ORGO) director 48,828 RSUs vesting 2027 - Stock Titan
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
48,828 RSUs granted to Organogenesis (ORGO) director Arthur Leibowitz - Stock Titan
What’s the fair value of Organogenesis Holdings Inc. stockJuly 2025 Price Swings & Verified Momentum Stock Ideas - mfd.ru
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 113% Potential Upside in Healthcare Innovation - DirectorsTalk Interviews
Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading CompaniesGilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More - Yahoo Finance
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 - The Manila Times
Regenerative medicine firm Organogenesis sets Feb. 26 call on 2025 results - Stock Titan
Organogenesis (NASDAQ: ORGO) VP uses 18,619 shares to cover tax liability - Stock Titan
Published on: 2026-02-18 01:47:23 - mfd.ru
Organogenesis (NASDAQ: ORGO) holder First Light reports 2.85% stake - Stock Titan
Will Organogenesis Holdings Inc. benefit from rate cutsTrade Exit Report & Reliable Breakout Forecasts - mfd.ru
ORGO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Organogenesis Holdings Inc. (ORGO) Stock Analysis: A Compelling 127% Upside Potential Amid Strong Revenue Growth - DirectorsTalk Interviews
ORGO Should I Buy - Intellectia AI
Is Organogenesis Holdings Inc. benefiting from innovation trends2025 Growth vs Value & Target Return Focused Stock Picks - mfd.ru
Soleus group holds 9.99M Organogenesis (ORGO) shares in passive stake - Stock Titan
Aug Analyst Calls: Is Organogenesis Holdings Inc. stock in correction or buying zoneTrade Risk Report & Fast Exit and Entry Trade Guides - mfd.ru
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vizsla Silver Corp. - GlobeNewswire Inc.
Is Organogenesis Holdings Inc impacted by rising ratesWeekly Trade Summary & Long Hold Capital Preservation Tips - baoquankhu1.vn
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a Potential 111.97% Upside - DirectorsTalk Interviews
Organogenesis Holdings Inc. (NASDAQ:ORGO) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough - 富途牛牛
Insider Sell: How does Organogenesis Holdings Inc. correlate with NasdaqQuarterly Profit Report & Daily Technical Forecast Reports - mfd.ru
Treasury Yields: Why is Primoris Services Corporation stock going downAnalyst Downgrade & Growth Oriented Trade Recommendations - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - Chartmill
Undervalued Opportunities: Penny Stocks To Watch In January 2026 - simplywall.st
The Truth About Organogenesis Holdings (ORGO): Quiet Biotech Sleeper Stock or Total Trap? - AD HOC NEWS
Is Organogenesis Holdings (NASDAQ:ORGO) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Analysis Recap: Is Organogenesis Holdings Inc backed by strong institutional buyingJuly 2025 Final Week & Real-Time Stock Movement Alerts - baoquankhu1.vn
Aug Macro: Is Organogenesis Holdings Inc a strong growth stockJuly 2025 Action & Accurate Intraday Trade Tips - baoquankhu1.vn
About Us - FinancialContent
The Market Doesn't Like What It Sees From Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Revenues Yet As Shares Tumble 28% - simplywall.st
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):